Sign Up to like & get
recommendations!
0
Published in 2022 at "ACS Applied Materials & Interfaces"
DOI: 10.1021/acsami.2c09641
Abstract: Using the biomarker hypermethylated DNA (hmDNA) for cancer detection requires a pretreatment to isolate or concentrate hmDNA from nonmethylated DNA. Affinity chromatography using a methyl binding domain-2 (MBD2) protein can be used, but the relatively…
read more here.
Keywords:
control mbd2;
hypermethylated dna;
receptor;
density control ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Oncogenesis"
DOI: 10.1038/s41389-021-00366-3
Abstract: Acute myeloid leukemia (AML) is a deadly cancer characterized by an expanded self-renewal capacity that is associated with the accumulation of immature myeloid cells. Emerging evidence shows that methyl-CpG-binding domain protein 2 (MBD2), a DNA…
read more here.
Keywords:
cell cycle;
loss mbd2;
mbd2;
mll af9 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Science Advances"
DOI: 10.1126/sciadv.aav9810
Abstract: The intrinsically disordered region of MBD2 is a promising target for treating cancer metastasis. Although intrinsically disordered protein regions (IDPRs) are commonly engaged in promiscuous protein-protein interactions (PPIs), using them as drug targets is challenging…
read more here.
Keywords:
rational discovery;
mbd2;
region mbd2;
intrinsically disordered ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer research"
DOI: 10.1158/0008-5472.can-17-1434
Abstract: Aberrant DNA methylation patterns in leukemia might be exploited for therapeutic targeting. In this study, we employed a genetically deficient mouse model to explore the role of the methylated DNA binding protein MBD2 in normal…
read more here.
Keywords:
wnt signaling;
mbd2 ablation;
mbd2;
progression maintenance ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Endocrine Connections"
DOI: 10.1530/ec-25-0169
Abstract: Small intestinal neuroendocrine tumors (SI-NETs) represent the most frequent neoplasms of the small intestine, with loss of chromosome 18 as the most common genetic aberration. To date, no highly frequently mutated genes have been identified…
read more here.
Keywords:
mbd2;
tumor;
cell;
neuroendocrine tumors ... See more keywords